Our latest Blogs
Stay informed with the latest updates, insights, and research news from Stackhaus Research. Our blog covers industry trends, scientific breakthroughs, product education, and best practices for responsible research.
SS-31 (Elamipretide) Deep Dive: Cardiolipin Targeting, Six Research Domains, and the 2026 Study Surge
A comprehensive research overview of SS-31 (elamipretide) — the mitochondria-targeted tetrapeptide studied for cardiolipin stabilization, electron transport chain integrity, and six active preclinical research domains including cardiac protection, skeletal muscle bioenergetics, neurological injury recovery, and the 2026 study surge.
Best Peptide Companies in 2026: A Researcher’s Evaluation Guide
Research Use Only Research Peptide Best Peptide Companies in 2026: A Researcher’s Evaluation Guide The peptide vendor landscape shifted materially in 2026. Peptide Sciences — one of the largest US-based RUO suppliers — ceased operations on March 6, 2026, creating an immediate supply gap for research teams that had relied…
Best Peptide Companies in 2026: A Researcher’s Evaluation Guide
What separates research-grade peptide vendors in 2026 — COA standards, US sourcing, RUO compliance, and the evaluation criteria the research community is actually using.
Shop Our Premium Peptides
Every product is backed by third-party verification – so you know exactly what you’re working with.